Vivo Capital, LLC Corvus Pharmaceuticals, Inc. Transaction History
Vivo Capital, LLC
- $368 Million
- Q1 2025
A detailed history of Vivo Capital, LLC transactions in Corvus Pharmaceuticals, Inc. stock. As of the latest transaction made, Vivo Capital, LLC holds 2,234,566 shares of CRVS stock, worth $10.1 Million. This represents 1.93% of its overall portfolio holdings.
Number of Shares
2,234,566
Previous 2,234,566
-0.0%
Holding current value
$10.1 Million
Previous $11.6 Million
38.85%
% of portfolio
1.93%
Previous 2.27%
Shares
2 transactions
Others Institutions Holding CRVS
# of Institutions
113Shares Held
39.9MCall Options Held
1.37MPut Options Held
338K-
Orbimed Advisors LLC San Diego, CA6.94MShares$31.2 Million0.69% of portfolio
-
Samlyn Capital, LLC New York, NY4.07MShares$18.3 Million0.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.28MShares$14.8 Million0.0% of portfolio
-
Adams Street Partners LLC Chicago, IL3.28MShares$14.7 Million9.69% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.79MShares$12.5 Million0.02% of portfolio
About Corvus Pharmaceuticals, Inc.
- Ticker CRVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,553,500
- Market Cap $209M
- Description
- Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The compan...